Cargando…
G protein-coupled KISS1 receptor is overexpressed in triple negative breast cancer and promotes drug resistance
Triple-negative breast cancer (TNBC) lacks the expression of estrogen receptor α, progesterone receptor and human epidermal growth factor receptor 2 (HER2). TNBC patients lack targeted therapies, as they fail to respond to endocrine and anti-HER2 therapy. Prognosis for this aggressive cancer subtype...
Autores principales: | Blake, Alexandra, Dragan, Magdalena, Tirona, Rommel G., Hardy, Daniel B., Brackstone, Muriel, Tuck, Alan B., Babwah, Andy V., Bhattacharya, Moshmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395950/ https://www.ncbi.nlm.nih.gov/pubmed/28422142 http://dx.doi.org/10.1038/srep46525 |
Ejemplares similares
-
KISS1/KISS1R in Cancer: Friend or Foe?
por: Guzman, Stephania, et al.
Publicado: (2018) -
The matrix protein Fibulin-3 promotes KISS1R induced triple negative breast cancer cell invasion
por: Noonan, Michelle M., et al.
Publicado: (2018) -
Kisspeptin/KISS1R System in Breast Cancer
por: Cvetković, Donna, et al.
Publicado: (2013) -
G protein-coupled kisspeptin receptor induces metabolic reprograming and tumorigenesis in estrogen receptor-negative breast cancer
por: Dragan, Magdalena, et al.
Publicado: (2020) -
The pregnant mouse uterus exhibits a functional kisspeptin/KISS1R signaling system on the day of embryo implantation
por: Fayazi, Mehri, et al.
Publicado: (2015)